Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) 2024-02, Vol.109 (2), p.689-692
Main Authors: Begna, Kebede H, Abdallah, Nadine H, Janania-Martinez, Michelle, Mangaonkar, Abhishek A, Rangan, Aruna, Herrick, Jennifer L, Gangat, Naseema
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal
Brentuximab Vedotin
Case Report
Hematopoietic Stem Cell Transplantation
Humans
Immunoconjugates - therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Stem Cell Transplantation
T-Lymphocytes
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0390-6078
1592-8721
1592-8721
DOI:10.3324/haematol.2023.283740